T. S. Hall

发表

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

D. Atar, C. Held, B. Lewis, 2022, European heart journal.

The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.

D. Atar, T. S. Hall, 2021, European journal of internal medicine.

Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS).

D. Atar, S. Agewall, V. Serebruany, 2018, European heart journal. Cardiovascular pharmacotherapy.

Ivabradine for heart failure: regulatory differences in Europe and United States.

D. Atar, S. Agewall, V. Serebruany, 2019, European Heart Journal - Cardiovascular Pharmacotherapy.

Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention

Anne Line Stensjøen, D. Atar, D. Erlinge, 2020, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging.

D. Atar, J. Dubois-Randé, Y. Birnbaum, 2018, Journal of electrocardiology.

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.

D. Atar, K. Dickstein, F. Zannad, 2018, International journal of cardiology.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

Novel aspects of cardiovascular biomarkers in myocardial infarction and obstructive sleep apnea

T. S. Hall, 2015 .

Morten Wang Fagerland, D. Atar, S. Agewall, 2014, Sleep medicine.

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

D. Atar, M. Krucoff, A. Lincoff, 2015, American heart journal.

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.

D. Atar, S. Solomon, K. Dickstein, 2019, American heart journal.

Obstructive sleep apnea: no independent association to troponins

Morten Wang Fagerland, D. Atar, S. Agewall, 2014, Sleep and Breathing.

Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy.

D. Atar, S. Jensen, P. Clemmensen, 2017, Journal of electrocardiology.

The significance of ST‐elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging

D. Atar, J. Dubois-Randé, Y. Birnbaum, 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction.

D. Atar, J. Kastrup, J. Dubois-Randé, 2017, Journal of electrocardiology.

Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging.

D. Atar, D. Shah, J. Dubois-Randé, 2017, Journal of electrocardiology.

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

M. Krucoff, A. Lincoff, M. Roe, 2015, American heart journal.